CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $805,783 | +230.5% | 20,973 | +99.1% | 0.00% | +100.0% |
| Q1 2023 | $243,816 | -21.2% | 10,532 | -10.8% | 0.00% | 0.0% |
| Q4 2022 | $309,448 | +46.7% | 11,811 | +9.5% | 0.00% | 0.0% |
| Q3 2022 | $211,000 | -1.4% | 10,788 | -17.3% | 0.00% | – |
| Q1 2022 | $214,000 | -17.7% | 13,041 | -18.4% | 0.00% | -100.0% |
| Q4 2021 | $260,000 | +47.7% | 15,981 | +15.7% | 0.00% | – |
| Q3 2021 | $176,000 | -22.8% | 13,812 | -14.6% | 0.00% | -100.0% |
| Q2 2021 | $228,000 | – | 16,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |